Corbus Pharmaceuticals
CRBP
CRBP
30 hedge funds and large institutions have $5.26M invested in Corbus Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 13 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less funds holding
Funds holding: 63 → 30 (-33)
89% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 36
Holders
30
Holding in Top 10
–
Calls
$260K
Puts
$4K
Top Buyers
| 1 | +$1.3M | |
| 2 | +$1.09M | |
| 3 | +$323K | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$266K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$99.5K |
Top Sellers
| 1 | -$82.4K | |
| 2 | -$63K | |
| 3 | -$56.3K | |
| 4 |
BlackRock
New York
|
-$46.3K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$31K |